Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$36.48 - $52.22 $2,152 - $3,080
-59 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$33.11 - $55.01 $1,953 - $3,245
59 New
59 $3,000
Q4 2018

Feb 14, 2019

SELL
$55.63 - $73.24 $7,343 - $9,667
-132 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$52.05 - $66.51 $5,309 - $6,784
102 Added 340.0%
132 $9,000
Q2 2018

Aug 10, 2018

SELL
$48.33 - $55.64 $1,304 - $1,502
-27 Reduced 47.37%
30 $2,000
Q1 2018

May 15, 2018

BUY
$44.44 - $54.39 $2,533 - $3,100
57 New
57 $3,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $561M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Signet Financial Management, LLC Portfolio

Follow Signet Financial Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signet Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signet Financial Management, LLC with notifications on news.